Pfizer Inc.
PFE.DE
Get informed when a big investor buys or sells
+ FollowMarket Cap$158.44B
Close$
Share Statistics
| Market cap | $158.44 Billion |
|---|---|
| Enterprise Value | $221.32 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 5.09% |
|---|---|
| Return on Assets | 2.16% |
| Return on Invested Capital | 4.22% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.47 |
| Enterprise Value to EBIT | 31.16 |
| Enterprise Value to Net Income | 51 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 0.75 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.60
Average shareholder expectationRevenue Estimate
$12.61 B
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$0.66
Average shareholder expectationRevenue Estimate
$14.02 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Pfizer Inc.
75,000 employees
CEO: Albert Bourla Pfizer Inc. operates as a leading global biopharmaceutical company, overseeing the entire lifecycle of its medicinal products—from initial discovery and rigorous development to worldwide manufacturing, strategic marketing, and extensive ...